| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |